Literatur
-
1
Assmann G, Cullen P, Schulte H.
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study.
Circulation.
2002;
105
310-315
-
2
Berg A, Halle M, Baumstark M W, Keul J.
Bedeutung der Lipoproteine bei der Pathogenese der KHK. Die Rolle der körperlichen Aktivität.
Dtsch Ärztebl.
1994;
91
A822-A830
-
3
Berg A.
Körperliche Aktivität und Übergewicht - was können Sport und Bewegung leisten?.
Akt Ernährungs Med.
2003;
28
1-8
-
4
Berg A, Frey I, Deibert P, Landmann U, König D, Schmidt-Trucksäß A, Rücker G, Kreiter H, Berg A, Dickhuth H H.
Gewichtsreduktion ist machbar - Halbjahresergebnisse einer klinisch kontrollierten, randomisierten Interventionsstudie mit übergewichtigen Erwachsenen.
Ernährungs Umschau.
2003;
50
386-393
-
5
Blüher M, Paschke R.
Bedeutung des viszeralen Fettgewebes für das metabolische Syndrom.
Dtsch Med Wochenschr.
2003;
128
2319-2323
-
6
Bray G A, Ryan D H.
Clinical evaluation of the overweight patient.
Endocrine.
2000;
13
167-186
-
7
Chobanian A V, Bakris G L, BlackHR, Cushman W C, Green L A, Izzo J L, Jones D W, Materson B J, Oparil S, Wright J T, Roccella E J.
The seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
JAMA.
2003;
289
2560-2572
-
8
Curb J D, Pressel S L, Cutler J A. et al .
Effect of diuretic based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
JAMA.
1996;
276
1886-1892
-
9
Davis B R, Blaufox M D, Hawkins C M. et al .
Trial of antihypertensive interventions and management. Design, methods, and selected baseline results.
Controlled Clin Trials.
1989;
10
11-30
-
10
Despres J P, Couillard C, Gagnon J, Bergeron J, Leon A S, Rao D C, Skinner J S, Wilmore J H, Bouchard C.
Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study.
Arterioscler Thromb Vasc Biol.
2000;
20
1932-1938
-
11
Despres J P, Gagnon J, Bergeron J, Couillard C, Leon A S, Rao D C, Skinner J S, Wilmore J H, Bouchard C.
Plasma post-heparin lipase activities in the HERITAGE Family Study: the reproducibility, gender differences, and associations with lipoprotein levels. Health, risk factors, exercise training and Genetics.
Clin Biochem.
1999;
32
157-165
-
12
Ernst N D, Cleeman J I.
National cholesterol education program keeps a priority on lifestyle modification to decrease cardiovascular disease risk.
Curr Opin Lipidol.
2002;
13
69-73
-
13
Fogelholm M, Kukkonen-Harjula K.
Does physical activity prevent weight gain? - a systematic review.
Obes Rev.
2000;
1
95-111
-
14
Folsom A R, Eckfeldt J H, Weitzman S. et al .
Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity.
Stroke.
1994;
25
66-73
-
15
Galanis D J, Harris T, Sharp D S, Petrovitch H.
Relative weight, weight change, and risk of coronary heart disease in the Honolulu Heart Program.
Am J Epidemiol.
1998;
147
379-386
-
16
Guidelines Committee .
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.
J Hypertens.
2003;
21
1011-1053
-
17
Gress T W, Nieto F J, Shahar E.
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus.
N Engl J Med.
2000;
342
905-912
-
18
Halle M, Berg A, Garwers U, Baumstark M W, Knisel W, Grathwohl D, König D, Keul J.
Influence of 4 weeks’ intervention by exercise and diet on low-density lipoprotein subfractions in obese men with type 2 diabetes.
Metabolism.
1999;
48
641-644
-
19
Hauner H, Berg A.
Körperliche Bewegung zur Prävention und Behandlung der Adipositas.
Dtsch Ärztebl.
2000;
97
660-665
-
20
Heart Outcome Prevention Evaluation (HOPE) Study Investigators .
Effect of ramipril on cardiovascular und microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy.
Lancet.
2000;
355
1755-1762
-
21
Helmrich S P, Ragland D R, Leung R W, Paffenbarger R S.
Physical activity and reduced occurrance of non-insulin-dependent diabetes mellitus.
N Engl J Med.
1991;
325
147-152
-
22
Julius S, Kjeldsen S E, Weber M, Brunner H R, Ekman S, Hansson L, Hua T, Laragh J, McInnes G T, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A.
Outcomes in hypertensive patients at high cardiovascular risk treated with regimes based on valsartan or amlodipine: the VALUE randomised trial.
Lancet.
2004;
363
2022-2031
-
23 König D, Deibert P, Frey I, Landmann U, Dickhuth H H, Berg A. Prävalenz von metabolischen Risikofaktoren bei Übergewichtigen. 38. Deutscher Kongess für Sportmedizin und Prävention, Potsdam KV084 2002
-
24
Krauss R M.
The tangled web of coronary risk factors.
Am J Med.
1991;
90
S36-S41
-
25
Kyle U G, Genton L, Pichard C.
Body composition: what’s new?.
Curr Opin Clin Nutr Metab Care.
2002;
5
427-433
-
26
Larsson B, Svärsund K, Welin L. et al .
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death.
Br med J.
1984;
288
1401-1404
-
27
Lee I M, Manson J E, Hennekens C H, Paffenbarger R S.
Body weight and mortality. A 27 year follow-up of middle-aged men.
JAMA.
1993;
270
2823-2828
-
28
Leibel R L, Rosenbaum M, Hirsch J.
Changes in energy expenditure resulting from altered body weight.
N Engl J Med.
1995;
332
621-628
-
29
Lindholm L H, Ibsen H, Dahlöf B. et al .
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet.
2002;
359
1004-1010
-
30
Manson J E, Colditz G A, Stampfer M J. et al .
A prospective study of obesity and risk of coronary heart disease in women.
N Engl J Med.
1990;
322
882-889
-
31
Mokdad A H, Bowman B A, Ford E S, Vinicor F, Marks J S, Koplan J P.
The continuing epidemics of obesity and diabetes in the United States.
JAMA.
2001;
286
1195-1200
-
32
Peeters A, Barendregt J J, Willekens F, Mackenbach J P, Al Mamun A, Bonneux L.
Obesity in adulthood and its consequences for life expectancy: a life-table analysis.
Ann Intern Med.
2003;
138
24-32
-
33
Rosenbloom A L, Joe J R, Young R S, Winter W E.
Emerging epidemic of type 2 diabetes in youth.
Diabetes Care.
1999;
22
345-354
-
34
Schmidt-Trucksass A, Baumstark M W, Daub C, Espenschied S, Grathwohl D, Berg A.
Lipoprotein phenotype and adhesion molecules correlate with diurnal triglyceride profiles in patients with coronary artery disease.
Nutr Metab Cardiovasc Dis.
2004;
14
20-25
-
35
Schulte H, Cullen P, Assmann G.
Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM).
Atherosclerosis.
1999;
144
199-209
-
36
Tuomiletho J, Rastenyte D, Birkenhäger W H. et al .
Effects of Calcium channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
N Engl J Med.
1999;
340
677-684
-
37
UK Prospective Diabetes Study Group .
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39.
BMJ.
1998;
317
713-721
-
38
Waaler H T.
Height, weight and mortality: The Norwegian Experience.
Acta Med Scand.
1984;
679
(Suppl)
1-56
-
39
Westerterp K R, Meijer E P.
Physical activity and parameters of aging: a physiological perspective.
J Gerontol A Biol Sci Med Sci.
2001;
56
(Spec 2)
7-12
-
40
Willett W C, Manson J E, Stampfer M J. et al .
Weight, weight change, and coronary heart disease in women. Risk within the ‘normal’ weight range.
JAMA.
1995;
273
461-465
-
41
Wirth A.
Anhaltende Gewichtsreduktion nach Beendigung der Adipositasbehandlung mit Sibutramin.
Dtsch Med Wochenschr.
2004;
129
1002-1005
Prof. Dr. med. Aloys Berg
Abtlg. Prävention und Rehabilitative Sportmedizin, Klinikum der Albert-Ludwigs-Universität
Hugstetterstraße 55
79106 Freiburg
